Phico Therapeutics Limited

#04062313 • Active

Phico Therapeutics is a biotechnology company focused on developing innovative antibacterial therapies to combat antibiotic resistance. Their proprietary SASPject technology delivers targeted proteins to inactivate bacterial DNA, offering a new approach to treating infections caused by multi-drug resistant bacteria.

Founded: 30 Aug 2000
Industries:
21100 - Manufacture of basic pharmaceutical products72110 - Research and experimental development on biotechnology
Website: phicotx.co.uk
Phone: +44(0)1954741040
Email: info@phicotx.co.uk
Location: Milton Keynes

Products & Services

• antibacterial
• antibiotic resistance
• biotechnology
• biotechnology company
• saspject
• saspject pt1.2
• saspject pt3.9
• saspject pt4
• saspject pt5
• targeted therapy

People

Officers
5
Shareholders
217
Controllers (PSC)
1
Mark Harvey Wilcox
Director • British • Lives in England • Born in Jan 1962
David Colin Beadle
Director • British • Lives in England • Born in Nov 1968
Richard Nagle
Director • British • Lives in England • Born in Oct 1966
Ian Downing
Director • British • Lives in England • Born in Jan 1969
Heather Marie Fairhead
Director • British • Lives in England • Born in Aug 1956
See Key People →

Registered Office Address

1 Radian Court

Knowlhill

Milton Keynes

MK5 8PJ

View on Map →

Basic Information

LTD
30 Aug 2000
ENGLAND WALES
Yes

Industry Classification

21100, 72110

Company Attributes

Yes
N/A
Yes
N/A

Summary

19
Officers
1
PSCs
0
Filings